 |
|
  |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
San Francisco AIDS Foundation
Bulletin of Experimental Treatments for AIDS
|
E-Mail
Printable Single-Page
Glossary
PDF
Share |
Features
- Overcoming Depression
By Lisa Capaldini, M.D., and George Harrison, M.D. - Oral Health and HIV
By David I. Rosenstein, D.M.D., M.P.H. - Insulin Resistance and Diabetes
By Liz Highleyman
Departments
- Editor's Note
By Nicholas Cheonis - In Their Own Words: AIDS Advocates
- News Briefs
By Liz Highleyman - Tipranavir: The First Nonpeptidic Protease Inhibitor
By Nicholas Cheonis - Women and HIV: Mother-to-Child Transmission -- How Will AZT and Nevirapine Use for MTCT Affect Future Treatment?
By Theo Smart - Open Clinical Trials
Notice
The statements and opinions in BETA are published as an educational resource only, and do not imply recommendation or endorsement by BETA or the San Francisco AIDS Foundation. Always consult a physician before taking any drug or changing a drug regimen.
|
Bulletin of Experimental Treatments for AIDS Editorial Staff:
Contributors to this issue: Lisa Capaldini, M.D.; Nicholas Cheonis; George Harrison, M.D.; Liz Highleyman; David I. Rosenstein, D.M.D., M.P.H.; Theo Smart Scientific Advisory Committee: George Beatty, M.D., M.P.H.; Lisa Capaldini, M.D.; Eric Goosby, M.D.; Cristina Gruta, Pharm.D.; Gregory Pauxtis, M.D. Copyright Editorial office and mailing address: |
This article was provided by San Francisco AIDS Foundation. It is a part of the publication Bulletin of Experimental Treatments for AIDS.
